Read + Share
Jian H, Wang K, Cheng Y, Ding L, et al. Phase I Trial of a Third Generation EGFR Mutant-Selective Inhibitor (D-0316) in
Patients with Advanced Non-Small Cell Lung Cancer. Oncologist 2022;27:163-e213.
PMID: 35274722
|
 |
|
Jian H, Wang K, Cheng Y, Ding L, et al. Phase I Trial of a Third Generation EGFR Mutant-Selective Inhibitor (D-0316) in
Patients with Advanced Non-Small Cell Lung Cancer. Oncologist 2022;27:163-e213.
PMID: 35274722
|
|
|
|